Microsoft Teams
Join the meeting now 
Meeting ID: 280 324 626 500 3 
Passcode: 4tr66GS7

Neuro-Oncology
Jessica White, M.D., M.P.H.
"Updates on Tumor Predisposition Syndromes"

Learning objectives: 
Upon conclusion of this activity, participants will be able to:

• Describe new medications available for treatment of plexiform neurofibromas in patients with neurofibromatosis type 1
• Identify patients who have NF2-related schwannomatosis per updated criteria
• Recommend appropriate surveillance for patients with Von Hippel Lindau Disease

Dr. Whited does not have any relevant financial relationships to disclose and does not intend to discuss any off-label/investigative use of Pharmaceuticals or Instruments. 

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.